Consistently, the protein levels of cyclin B1, cyclin D2, and CDK2 were decreased after ADORA2A-AS1 knockdown in CML cells (Figure 3(d)). The gene discussed is ADORA2A; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.